Pharmaceutical nanotechnology Poorly water-soluble drug nanoparticles via solvent evaporation in water-soluble porous polymers

International Journal of Pharmaceutics

Volumn 447, Issue 1-2, 2013, Pages 241-250

  Roberts, Aled D ^a   Zhang, Haifei ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Aqueous nanosuspension; Carbamazepine; Drug nanocrystals; Griseofulvin; Paclitaxel; Poorly water soluble drugs

Indexed keywords

CARBAMAZEPINE; GRISEOFULVIN; NANOPARTICLE; PACLITAXEL; POROUS POLYMER; ANTICONVULSIVE AGENT; ANTIFUNGAL AGENT; ANTINEOPLASTIC AGENT; MACROGOL DERIVATIVE; POLYVINYL ALCOHOL; SOLVENT; SURFACTANT; WATER;

AQUEOUS SOLUTION; ARTICLE; CONTROLLED STUDY; EVAPORATION; FREEZE DRYING; PARTICLE SIZE; PRIORITY JOURNAL; SURFACE CHARGE; SUSPENSION; ZETA POTENTIAL; CHEMISTRY; DRUG FORMULATION; METHODOLOGY; POROSITY; SCANNING ELECTRON MICROSCOPY; SOLUBILITY; SURFACE PROPERTY; TRANSMISSION ELECTRON MICROSCOPY; ULTRASTRUCTURE; VOLATILIZATION;

ANTICONVULSANTS; ANTIFUNGAL AGENTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CARBAMAZEPINE; DRUG COMPOUNDING; GRISEOFULVIN; MICROSCOPY, ELECTRON, SCANNING; MICROSCOPY, ELECTRON, TRANSMISSION; NANOPARTICLES; PACLITAXEL; PARTICLE SIZE; POLYETHYLENE GLYCOLS; POLYVINYL ALCOHOL; POROSITY; SOLUBILITY; SOLVENTS; SURFACE PROPERTIES; SURFACE-ACTIVE AGENTS; VOLATILIZATION; WATER;

EID: 84876051693     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2013.03.001     Document Type: Article

References (44)

1. M.L. Adams, A. Lavasanifar, and G.S. Kwon Amphiphilic block copolymers for drug delivery J. Pharm. Sci. 92 2003 1343 1355
2. S. Ali, and K. Kolter Challenges and opportunities in oral formulation development Am. Pharm. Rev. 15 7 2012
3. I. Aranaz, M.C. Gutierrez, L. Yuste, F. Rojo, M.L. Ferrer, and F. del Monte Controlled formation of the anhydrous polymorph of ciprofloxacin crystals embedded within chitosan scaffolds: study of the kinetic release dependence on crystal size J. Mater. Chem. 19 2009 1576 1582
4. H. Cabral, Y. Matsumoto, K. Mizuno, Q. Chen, M. Murakami, M. Kimura, Y. Terada, M.R. Kano, K. Miyazono, M. Uesaka, N. Nishiyama, and K. Kataoka Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size Nat. Nanotechnol. 6 2011 815 823
5. 2 antisolvent with enhanced mass transfer Int. J. Pharm. 228 2001 19 31
6. A.M. Dwivedi Residual solvent analysis in pharmaceuticals Pharm. Technol. North Am. 26 2002 42 46
7. X. Feng, Y.-J. Yuan, and J.-C. Wu Synthesis and evaluation of water-soluble paclitaxel prodrugs Bioorg. Med. Chem. Lett. 12 2002 3301 3303
8. Q. Fu, J. Sun, W. Zhang, X. Sui, Z. Yan, and Z. He Nanoparticle albumin - bound (NAB) technology is a promising method for anti-cancer drug delivery Recent Pat. Anticancer Drug Discov. 4 2009 262 272
9. H. Gelderblom, J. Verweij, K. Nooter, and A. Sparreboom Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation Eur. J. Cancer 37 2001 1590 1598
10. W.J. Gradishar Albumin-bound paclitaxel: a next-generation taxane Expert Opin. Pharmacother. 7 2006 1041 1053
11. N. Grant, and H. Zhang Poorly water-soluble drug nanoparticles via an emulsion-freeze-drying approach J. Colloid Interface Sci. 356 2011 573 578
12. M. Hiroshi The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting Adv. Enzyme Regul. 41 2001 189 207
13. D. Horn, and J. Rieger Organic nanoparticles in the aqueous phase - theory, experiment, and use Angew. Chem. Int. Ed. 40 2001 4330 4361
14. C. Hoskins, P.K. Thoo-Lin, and W.P. Cheng A review on comb-shaped amphiphilic polymers for hydrophobic drug solubilization Ther. Deliv. 3 2012 59 79
15. G. Hu, H. Li, X. Wang, and Y. Zhang Measurement and correlation of griseofulvin solubility in different solvents at temperatures from (281.95 to 357.60) K J. Chem. Eng. Data 55 2010 3969 3971
16. S. Kamiya, T. Kurita, A. Miyagishima, and M. Arakawa Preparation of griseofulvin nanoparticle suspension by high-pressure homogenization and preservation of the suspension with saccharides and sugar alcohols Drug Develop. Ind. Pharm. 35 2009 1022 1028
17. N.A. Kasim, M. Whitehouse, C. Ramachandran, M. Bermejo, H. Lennernäs, A.S. Hussain, H.E. Junginger, S.A. Stavchansky, K.K. Midha, V.P. Shah, and G.L. Amidon Molecular properties of WHO essential drugs and provisional biopharmaceutical classification Mol. Pharm. 1 2003 85 96
18. M.J. Lawrence, and G.D. Rees Microemulsion-based media as novel drug delivery systems Adv. Drug Delivery Rev. 45 2000 89 121
19. J. Lee Drug nano- and micro-particles processed into solid dosage forms: physical properties J. Pharm. Sci. 92 2003 2057 2068
20. C. Lipinski Poor aqueous solubility - an industry wide problem in drug discovery Am. Pharm. Rev. 5 2002 82 85
21. Y. Liu, H. Miyoshi, and M. Nakamura Nanomedicine for drug delivery and imaging: a promising avenue for cancer therapy and diagnosis using targeted functional nanoparticles Int. J. Cancer 120 2007 2527 2537
22. Y. Liu, P. Xie, D. Zhang, and Q. Zhang A mini review of nanosuspensions development J. Drug Target. 20 2012 209 223
23. N. Masahiro Places of emulsions in drug delivery Adv. Drug Delivery Rev. 45 2000 1 4
24. S.M. Moghimi, and J. Szebeni Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties Prog. Lipid Res. 42 2003 463 478
25. R.H. Müller, S. Gohla, and C.M. Keck State of the art of nanocrystals - special features, production, nanotoxicology aspects and intracellular delivery Eur. J. Pharm. Biopharm. 78 2011 1 9
26. D.W. Nyman, K.J. Campbell, E. Hersh, K. Long, K. Richardson, V. Trieu, N. Desai, M.J. Hawkins, and D.D. Von Hoff Phase I and pharmacokinetics trial of ABI-007, a novel nanoparticle formulation of paclitaxel in patients with advanced nonhematologic malignancies J. Clin. Oncol. 23 2005 7785 7793
27. V.B. Patravale, A.A. Date, and R.M. Kulkarni Nanosuspensions: a promising drug delivery strategy J. Pharm. Pharmacol. 56 2004 827 840
28. L. Qian, A. Ahmed, A. Foster, S.P. Rannard, A.I. Cooper, and H. Zhang Systematic tuning of pore morphologies and pore volumes in macroporous materials by freezing J. Mater. Chem. 19 2009 5212 5219
29. L. Qian, A. Ahmed, and H. Zhang Formation of organic nanoparticles by solvent evaporation within porous polymeric materials Chem. Commun. 47 2011 10001 10003
30. L.Y. Qiu, and Y.H. Bae Polymer architecture and drug delivery Pharm. Res. 23 2006 1 30
31. S. Rannard, and A. Owen Nanomedicine: not a case of "One size fits all" Nano Today 4 2009 382 384
32. H.M. Redhead, S.S. Davis, and L. Illum Drug delivery in poly(lactide-co-glycolide) nanoparticles surface modified with poloxamer 407 and poloxamine 908: in vitro characterisation and in vivo evaluation J. Control. Release 70 2001 353 363
33. R.A. Schwendener, and H. Schott Lipophilic 1-β-d-arabinofuranosyl cytosine derivatives in liposomal formulations for oral and parenteral antileukemic therapy in the murine L1210 leukemia model J. Cancer Res. Clin. Oncol. 122 1996 723 726
34. R. Shegokar, and R.H. Müller Nanocrystals: industrially feasible multifunctional formulation technology for poorly soluble actives Int. J. Pharm. 399 2010 129 139
35. G. Shepherd Hypersensitivity reactions to chemotherapeutic drugs Clin. Rev. Allergy Immunol. 24 2003 253 262
36. A.K. Singla, A. Garg, and D. Aggarwal Paclitaxel and its formulations Int. J. Pharm. 235 2002 179 192
37. S. Svenson Dendrimers as versatile platform in drug delivery applications Eur. J. Pharm. Biopharm. 71 2009 445 462
38. J. Szebeni, C.R. Alving, and F.M. Muggia Complement activation by cremophor EL as a possible contributor to hypersensitivity to paclitaxel: an in vitro study J. Natl. Cancer Inst. 90 1998 300 306
39. M. Trotta, M. Gallarate, M.E. Carlotti, and S. Morel Preparation of griseofulvin nanoparticles from water-dilutable microemulsions Int. J. Pharm. 254 2003 235 242
40. T. Vasconcelos, B. Sarmento, and P. Costa Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs Drug Discov. Today 12 2007 1068 1075
41. P.G. Waser, U. Müller, J. Kreuter, S. Berger, K. Munz, E. Kaiser, and B. Pfluger Localization of colloidal particles (liposomes, hexylcyanoacrylate nanoparticles and albumin nanoparticles) by histology and autoradiography in mice Int. J. Pharm. 39 1987 213 227
42. F. Yuan, M. Dellian, D. Fukumura, M. Leunig, D.A. Berk, V.P. Torchilin, and R.K. Jain Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size Cancer Res. 55 1995 3752 3756
43. H. Zhang, D. Wang, R. Butler, N.L. Campbell, J. Long, B. Tan, D.J. Duncalf, A.J. Foster, A. Hopkinson, D. Taylor, D. Angus, A.I. Cooper, and S.P. Rannard Formation and enhanced biocidal activity of water-dispersable organic nanoparticles Nat. Nanotechnol. 3 2008 506 511
44. Y. Zhang, M. Yang, N. Portney, D. Cui, G. Budak, E. Ozbay, M. Ozkan, and C. Ozkan Zeta potential: a surface electrical characteristic to probe the interaction of nanoparticles with normal and cancer human breast epithelial cells Biomed. Microdev. 10 2008 321 328